INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,966 Cr | ₹1,180 Cr | ₹960 Cr | ₹690 Cr | ₹260 Cr |
What is the latest Net Current Assets ratio of INDEGENE ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹1,966 Cr |
| Mar2024 | ₹1,180 Cr |
| Mar2023 | ₹960 Cr |
| Mar2022 | ₹690 Cr |
| Mar2021 | ₹260 Cr |
How is Net Current Assets of INDEGENE Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,966 Cr | 66.58 | |
| Mar2024 | ₹1,180 Cr | 22.96 | |
| Mar2023 | ₹960 Cr | 39.16 | |
| Mar2022 | ₹690 Cr | 165.36 | |
| Mar2021 | ₹260 Cr | - | |
Compare Net Current Assets of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹11,194.1 Cr | -2.8% | -11.1% | -28.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹393,323.0 Cr | 1.7% | -5.7% | -7.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,825.0 Cr | 0.8% | -6.7% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,349.0 Cr | 0.6% | 4.3% | 24.4% | Stock Analytics | |
| CIPLA | ₹106,048.0 Cr | -4.7% | -12.3% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,494.0 Cr | 6.3% | -2.1% | -4.1% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | -2.8% |
-11.1% |
-28.1% |
| SENSEX | -1.7% |
-4.3% |
6.2% |
You may also like the below Video Courses